Invention Grant
US08476271B2 Substituted-quinoxaline-type bridged-piperidine compounds as ORL-1 modulators 有权
取代的喹喔啉型桥接哌啶化合物作为ORL-1调节剂

Substituted-quinoxaline-type bridged-piperidine compounds as ORL-1 modulators
Abstract:
Compounds of Formula (I): where R1, R2, R5, a, and b are disclosed herein, and pharmaceutically acceptable derivatives thereof (a “Substituted-Quinoxaline-Type Bridged-Piperidine Compound”), compositions comprising an effective amount of a Substituted-Quinoxaline-Type Bridged-Piperidine Compound, and methods to treat or prevent a condition, such as pain, comprising administering to an animal in need thereof an effective amount of a Substituted-Quinoxaline-Type Bridged-Piperidine Compound.
Information query
Patent Agency Ranking
0/0